Global Reporting Initiative Index

This report aligns with the GRI G3 Guidelines. Baxter self-declares this report to application level B. Please also see how Baxter addresses G3 reporting principles.

Disclosure Description 2012 Reporting
Strategy and Analysis
1.1 Statement from the most senior decision-maker of the organization about the relevance of sustainability to the organization and its strategy. Chairman and CEO Letter
1.2 Description of key impacts, risks, and opportunities. Chairman and CEO Letter
Priorities and Goals
Organizational Profile
2.1 Name of the organization. Company Profile
2.2 Primary brands, products, and/or services. Company Profile
2.3 Operational structure of the organization, including main divisions, operating companies, subsidiaries, and joint ventures. Company Profile
2.4 Location of organization's headquarters. Baxter's headquarters are located in Deerfield, Illinois, United States, approximately 20 miles north of Chicago.
2.5 Number of countries where the organization operates, and names of countries with either major operations or that are specifically relevant to the sustainability issues covered in the report. Company Profile
EHS Management Systems and Certifications
2.6 Nature of ownership and legal form. Baxter Healthcare Corporation (BAX) is a publicly traded company listed on the New York Stock Exchange.
2.7 Markets served. Company Profile
2.8 Scale of the reporting organization. Company Profile
Employees
Environment, Health and Safety
Supply Chain
2.9 Significant changes during the reporting period regarding size, structure, or ownership. Company Profile
2.10 Awards received in the reporting period. Awards and Honors
Report Parameters
3.1 Reporting period for information provided. Sustainability Reporting
3.2 Date of most recent previous report (if any). Downloads
3.3 Reporting cycle. Sustainability Reporting
3.4 Contact point for questions regarding the report or its contents. Sustainability Reporting
3.5 Process for defining report content. Baxter's Approach
Priorities and Goals
External Reporting Standards
Feedback on 2011 Report
3.6 Boundary of the report. Sustainability Reporting
Environment, Health and Safety
GHG Emissions across the Value Chain
3.7 State any specific limitations on the scope or boundary of the report. Sustainability Reporting
Environment, Health and Safety
3.8 Basis for reporting on joint ventures, subsidiaries, leased facilities, outsourced operations, and other entities that can significantly affect comparability from period to period and/or between organizations. Sustainability Reporting
3.9 Data measurement techniques and the bases of calculations, including assumptions and techniques underlying estimations applied to the compilation of the Indicators and other information in the report. Baxter Energy Usage and Greenhouse Gas Emissions
GHG Emissions across the Value Chain
GHG Emissions from Operations
2012 Environmental Financial Statement
2012 Safety Performance
Sustainable Procurement
Community Support
Summary Data Table (PDF)
3.10 Explanation of the effect of any re-statements of information provided in earlier reports, and the reasons for such re-statement. Environment, Health and Safety
3.11 Significant changes from previous reporting periods in the scope, boundary, or measurement methods applied in the report. Baxter Energy Usage and Greenhouse Gas Emissions
GHG Emissions across the Value Chain
3.12 Table identifying the location of the Standard Disclosures in the report. Global Reporting Initiative Index
3.13 Policy and current practice with regard to seeking external assurance for the report. Assurance
Governance, Commitments and Engagements
4.1 Governance structure of the organization, including committees under the highest governance body responsible for specific tasks, such as setting strategy or organizational oversight. Corporate Governance
4.2 Indicate whether the Chair of the highest governance body is also an executive officer. Corporate Governance
4.3 For organizations that have a unitary board structure, state the number of members of the highest governance body that are independent and/or non-executive members. Corporate Governance
4.4 Mechanisms for shareholders and employees to provide recommendations or direction to the highest governance body. How to Contact Baxter's Board of Directors
4.5 Linkage between compensation for members of the highest governance body, senior managers, and executives (including departure arrangements), and the organization's performance (including social and environmental performance). Baxter's Compensation Committee and Committee Charter
4.6 Processes in place for the highest governance body to ensure conflicts of interest are avoided. Corporate Goverance
Codes and Standards
4.7 Process for determining the qualifications and expertise of the members of the highest governance body for guiding the organization's strategy on economic, environmental, and social topics. Corporate Governance Guidelines
4.8 Internally developed statements of mission or values, codes of conduct, and principles relevant to economic, environmental, and social performance and the status of their implementation. Corporate Governance
Codes and Standards
Talent Management
Global Inclusion and Diversity
EHS Vision and Policy
R&D and Design
Clinical Trials
Supplier Standards
Product Donations
4.9 Procedures of the highest governance body for overseeing the organization's identification and management of economic, environmental, and social performance, including relevant risks and opportunities, and adherence or compliance with internationally agreed standards, codes of conduct, and principles. Corporate Governance
4.10 Processes for evaluating the highest governance body's own performance, particularly with respect to economic, environmental, and social performance. Corporate Governance Guidelines
4.11 Explanation of whether and how the precautionary approach or principle is addressed by the organization. Baxter's products are regulated by health authorities around the world and the company is required to provide extensive scientific data related to the safety and efficacy of those products in order to obtain licensure by regulatory authorities. See also R&D and Design and Materials Use.
4.12 Externally developed economic, environmental, and social charters, principles, or other initiatives to which the organization subscribes or endorses. Affiliations and Memberships
Codes and Standards
EHS Management Systems and Certifications
Biodiversity
GHG Emissions from Operations
Animal Welfare
Clinical Trials
Product Use
Supplier Standards
External Reporting Standards
4.13 Memberships in associations and/or national/international advocacy organizations. Affiliations and Memberships
4.14 List of stakeholder groups engaged by the organization. Stakeholder Engagement
4.15 Basis for identification and selection of stakeholders with whom to engage. Stakeholder Engagement
4.16 Approaches to stakeholder engagement, including frequency of engagement by type and by stakeholder group. Stakeholder Engagement
4.17 Key topics and concerns that have been raised through stakeholder engagement, and how the organization has responded to those key topics and concerns, including through its reporting. Feedback on 2011 Report
Economic
Disclosure on Management Approach Economic Impacts
Direct Impacts
Indirect Impacts
EC1 Economic value generated and distributed, including revenues, operating costs, employee compensation, donations and other community investments, retained earnings, and payments to capital providers and governments. (Core) Direct Impacts
EC2 Financial implications and other risks and opportunities for the organization's activities due to climate change. (Core) Baxter considers its exposure, during the next decade, to potential regulatory, physical and other risks related to climate change to be low. The company believes existing and anticipated government policies, legislation, regulations and energy standards aimed at improving energy efficiency and limiting and reducing greenhouse gas (GHG) emissions will pose minimal regulatory risk to the corporation, in part due to Baxter's proactive approach in this area. In the near-term, Baxter anticipates minimal physical risk to its business associated with global warming, resultant climate change, sea-level rise, change in weather patterns and precipitation. For more information, see Baxter's Carbon Disclosure Project submission. For more information, see Baxter's Carbon Disclosure Project submission.
EC3 Coverage of the organization's defined benefit plan obligations. (Core) 2012 Annual Report (page 82)
EC4 Significant financial assistance received from government. (Core) Not available on a companywide basis.
EC5 Range of ratios of standard entry level wage compared to local minimum wage at significant locations of operation. (Additional)  
EC6 Policy, practices, and proportion of spending on locally-based suppliers at significant locations of operation. (Core) Supplier Diversity
EC7 Procedures for local hiring and proportion of senior management hired from the local community at significant locations of operation. (Core) Baxter does not track this information globally.
EC8 Development and impact of infrastructure investments and services provided primarily for public benefit through commercial, in-kind, or pro bono engagement. (Core) Access to Healthcare
Community Support
EC9 Understanding and describing significant indirect economic impacts, including the extent of impacts. (Additional) Indirect Impacts
Environmental
Disclosure on Management Approach EHS Program
Product Responsibility
EN1 Materials used by weight or volume. (Core) Eco-Efficiency / Raw Materials Use
EN2 Percentage of materials used that are recycled input materials. (Core) Eco-Efficiency / Raw Materials Use
EN3 Direct energy consumption by primary energy source. (Core) Energy
Baxter Energy Usage and Greenhouse Gas Emissions
EN4 Indirect energy consumption by primary source. (Core) Energy
Baxter Energy Usage and Greenhouse Gas Emissions
EN5 Energy saved due to conservation and efficiency improvements. (Additional) Energy
EN6 Initiatives to provide energy-efficient or renewable energy based products and services, and reductions in energy requirements as a result of these initiatives. (Additional) GHG Emissions from Operations
Product Sustainability Review
EN7 Initiatives to reduce indirect energy consumption and reductions achieved. (Additional) Energy
Case Study: Employees Drive Innovative Environmental Initiatives
EN8 Total water withdrawal by source. (Core) Water and Wastewater
EN9 Water sources significantly affected by withdrawal of water. (Additional) Water and Wastewater
EN10 Percentage and total volume of water recycled and reused. (Additional)  
EN11 Location and size of land owned, leased, managed in, or adjacent to, protected areas and areas of high biodiversity value outside protected areas. (Core) Biodiversity
EN12 Description of significant impacts of activities, products, and services on biodiversity in protected areas and areas of high biodiversity value outside protected areas. (Core) Biodiversity
EN13 Habitats protected or restored. (Additional) Biodiversity
EN14 Strategies, current actions, and future plans for managing impacts on biodiversity. (Additional) Biodiversity
EN15 Number of IUCN Red List species and national conservation list species with habitats in areas affected by operations, by level of extinction risk. (Additional)  
EN16 Total direct and indirect greenhouse gas emissions by weight. (Core) GHG Emissions across the Value Chain
GHG Emissions from Operations
Baxter Energy Usage and Greenhouse Gas Emissions
EN17 Other relevant indirect greenhouse gas emissions by weight. (Core) GHG Emissions across the Value Chain
GHG Emissions from Operations
Baxter Energy Usage and Greenhouse Gas Emissions
EN18 Initiatives to reduce greenhouse gas emissions and reductions achieved. (Additional) GHG Emissions from Operations
Case Study: Employees Drive Innovative Environmental Initiatives
EN19 Emissions of ozone-depleting substances by weight. (Core) Air Emissions
EN20 NOx, SOx, and other significant air emissions by type and weight. (Core) Air Emissions
EN21 Total water discharge by quality and destination. (Core) Water and Wastewater
EN22 Total weight of waste by type and disposal method. (Core) Waste
EN23 Total number and volume of significant spills. (Core) Environmental Compliance
EN24 Weight of transported, imported, exported, or treated waste deemed hazardous under the terms of the Basel Convention Annex I, II, III, and VIII, and percentage of transported waste shipped internationally. (Additional)  
EN25 Identity, size, protected status, and biodiversity value of water bodies and related habitats significantly affected by the reporting organization's discharges of water and runoff. (Additional)  
EN26 Initiatives to mitigate environmental impacts of products and services, and extent of impact mitigation. (Core) Product Sustainability Review
Materials Use
Materials Restrictions
Manufacturing
Product Transport
Case Study: Decreasing Environmental Impact of Product Transportation
Packaging
Product End-of-Life
Sustainable Procurement
EN27 Percentage of products sold and their packaging materials that are reclaimed by category. (Core) The European Union packaging directive requires Baxter to reclaim packaging and to submit related reports. Baxter typically pays third parties fees of about $1 million per year to do this, as indicated on the company's Environmental Financial Statement. Baxter does not currently have systems to track quantities of packaging materials reclaimed. Baxter's products are primarily disposable medical products. Reclamation of these products is difficult since often they must be disposed of as biohazardous waste after their use. Baxter continues to explore means to reclaim and recycle products with its customers. See also Product End-of-Life.
EN28 Monetary value of significant fines and total number of non-monetary sanctions for non-compliance with environmental laws and regulations. (Core) Environmental Compliance
EN29 Significant environmental impacts of transporting products and other goods and materials used for the organization's operations, and transporting members of the workforce. (Additional) GHG Emissions across the Value Chain
GHG Emissions from Operations
Baxter Energy Usage and Greenhouse Gas Emissions
Product Transport
EN30 Total environmental protection expenditures and investments by type (Additional) 2012 Environmental Financial Statement
Labor Practices and Decent Work
Disclosure on Management Approach Talent Management
Sustainability Education
Compensation and Benefits
Measuring Company Culture
Global Inclusion and Diversity
Work/Life
LA1 Total workforce by employment type, employment contract, and region. (Core) Employees
LA2 Total number and rate of employee turnover by age group, gender, and region. (Core) Talent Management
LA3 Benefits provided to full-time employees that are not provided to temporary or part-time employees, by major operations. (Additional) Compensation and Benefits
Work/Life
LA4 Percentage of employees covered by collective bargaining agreements. (Core) Baxter does not track this information globally.
LA5 Minimum notice period(s) regarding significant operational changes, including whether it is specified in collective agreements. (Core) The length of the notice period is dependent on the type of change being made. Baxter is committed to providing appropriate notice and follows all relevant consultation and notice requirements.
LA6 Percentage of total workforce represented in formal joint management-worker health and safety committees that help monitor and advise on occupational health and safety programs. (Additional)  
LA7 Rates of injury, occupational diseases, lost days, and absenteeism, and number of work-related fatalities by region. (Core) 2012 Safety Performance
LA8 Education, training, counseling, prevention, and risk-control programs in place to assist workforce members, their families, or community members regarding serious diseases. (Core) Advancing Public Health
Product Donations
The Baxter International Foundation
LA9 Health and safety topics covered in formal agreements with trade unions. (Additional)  
LA10 Average hours of training per year per employee by employee category. (Core) Talent Management
LA11 Programs for skills management and lifelong learning that support the continued employability of employees and assist them in managing career endings. (Additional) Talent Management
Sustainability Education
LA12 Percentage of employees receiving regular performance and career development reviews. (Additional) Talent Management
LA13 Composition of governance bodies and breakdown of employees per category according to gender, age group, minority group membership, and other indicators of diversity. (Core) Global Inclusion and Diversity
LA14 Ratio of basic salary of men to women by employee category. (Core) Baxter does not track this information globally.
Human Rights
Disclosure on Management Approach Global Human Rights Policy
Supplier Standards
HR1 Percentage and total number of significant investment agreements that include human rights clauses or that have undergone human rights screening. (Core) Baxter does not track this information globally in a consistent manner. See also Supplier Standards.
HR2 Percentage of significant suppliers and contractors that have undergone screening on human rights and actions taken. (Core) Supplier Standards
Sustainable Procurement
HR3 Total hours of employee training on policies and procedures concerning aspects of human rights that are relevant to operations, including the percentage of employees trained. (Additional)  
HR4 Total number of incidents of discrimination and actions taken. (Core) In addition to alleged cases of discrimination and harassment that may be handled locally, Baxter's Ethics and Compliance helpline and information management system logged 15 allegations of discrimination and harassment in 2012. Baxter encourages employees to seek guidance and report concerns through a number of formal channels. Through these channels, Baxter identifies incidents, prevents incidents from occurring and addresses issues when they do arise. Items identified through these channels help Ethics and Compliance managers identify key risks, develop appropriate training, and design and apply compliance assessment methodologies.
HR5 Operations identified in which the right to exercise freedom of association and collective bargaining may be at significant risk, and actions taken to support these rights. (Core)
HR6 Operations identified as having significant risk for incidents of child labor, and measures taken to contribute to the elimination of child labor. (Core) See Baxter's Code of Conduct, page 9.
HR7 Operations identified as having significant risk for incidents of forced or compulsory labor, and measures to contribute to the elimination of forced or compulsory labor. (Core) See Baxter's Code of Conduct, page 9.
HR8 Percentage of security personnel trained in the organization's policies or procedures concerning aspects of human rights that are relevant to operations. (Additional)  
HR9 Total number of incidents of violations involving rights of indigenous people and actions taken. (Additional)  
Society
Disclosure on Management Approach Governance, Ethics and Compliance
Access to Healthcare
Community Support
Education and Critical Community Needs
Employee Involvement
SO1 Nature, scope, and effectiveness of any programs and practices that assess and manage the impacts of operations on communities, including entering, operating, and exiting. (Core) Environment, Health and Safety
SO2 Percentage and total number of business units analyzed for risks related to corruption. (Core) Baxter conducts an annual enterprise-wide risk assessment covering, among other things, legal risks such as corruption. Baxter also annually conducts intensive assessments of its business units that are designed to evaluate whether Baxter has appropriate anticorruption policies, processes, controls and training. The company conducted 20 such assessments outside the United States in 2012.
SO3 Percentage of employees trained in organization's anti-corruption policies and procedures. (Core) Codes and Standards
Ethics and Compliance - Structure and Programs
SO4 Actions taken in response to incidents of corruption. (Core) Allegations are investigated by the Ethics and Compliance department.
SO5 Public policy positions and participation in public policy development and lobbying. (Core) Public Policy
2012 Political Contributions Report
2011 Political Contributions Report
2010 Political Contributions Report
2009 Political Contributions Report
2008 Political Contributions Report
SO6 Total value of financial and in-kind contributions to political parties, politicians, and related institutions by country. (Additional) 2012 Political Contributions Report
2011 Political Contributions Report
2010 Political Contributions Report
2009 Political Contributions Report
2008 Political Contributions Report
SO7 Total number of legal actions for anti-competitive behavior, anti-trust, and monopoly practices and their outcomes. (Additional)  
SO8 Monetary value of significant fines and total number of non-monetary sanctions for non-compliance with laws and regulations. (Core) Environmental Compliance
Health and Safety Compliance
Safety
Product Use
Product Responsibility
Disclosure on Management Approach Product Responsibility
Quality
Safety
Product Integrity
R&D and Design
Materials Use
Manufacturing
Packaging
Product Use
Product End-of-Life
Product Transport
Advancing Public Health
Base of the Pyramid
Product Donations
PR1 Life cycle stages in which health and safety impacts of products and services are assessed for improvement, and percentage of significant products and services categories subject to such procedures. (Core) Product Sustainability Review
PR2 Total number of incidents of non-compliance with regulations and voluntary codes concerning health and safety impacts of products and services during their life cycle, by type of outcomes. (Additional) Safety
PR3 Type of product and service information required by procedures, and percentage of significant products and services subject to such information requirements. (Core) Clinical Trials
Product Use
PR4 Total number of incidents of non-compliance with regulations and voluntary codes concerning product and service information and labeling, by type of outcomes. (Additional)  
PR5 Practices related to customer satisfaction, including results of surveys measuring customer satisfaction. (Additional)  
PR6 Programs for adherence to laws, standards, and voluntary codes related to marketing communications, including advertising, promotion, and sponsorship. (Core) Product Use
PR7 Total number of incidents of non-compliance with regulations and voluntary codes concerning marketing communications, including advertising, promotion, and sponsorship by type of outcomes. (Additional) Product Use
PR8 Total number of substantiated complaints regarding breaches of customer privacy and losses of customer data. (Additional)  
PR9 Monetary value of significant fines for non-compliance with laws and regulations concerning the provision and use of products and services. (Core). Safety
Product Use